SCHEMBL15504372

SCHEMBL15504372

OCC1O[C@@H](OCc2ccccc2)[C@@H](O)C(O)[C@@H]1O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 2/20 0.57
▸ SYNJ2 O15056 2/20 0.56
▸ KDM4E B2RXH2 1/20 0.56
▸ ABL1 P00519 1/20 0.56
▸ ALPL P05186 1/20 0.56
▸ POLB P06746 1/20 0.56
▸ ALPI P09923 1/20 0.56
▸ GAA P10253 1/20 0.56
▸ MAPT P10636 1/20 0.56
▸ ALPG P10696 1/20 0.56
▸ PABPC1 P11940 1/20 0.56
▸ RECQL P46063 1/20 0.56
▸ GALK1 P51570 1/20 0.56
▸ CASP7 P55210 1/20 0.56
▸ CASP6 P55212 1/20 0.56
▸ MCL1 Q07820 1/20 0.56
▸ RIN1 Q13671 1/20 0.56
▸ EIF4H Q15056 1/20 0.56
▸ SLC5A2 P31639 1/20 0.54
▸ TYR P14679 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9001318 1.00 SLC6A2 (0.57) SLC6A2SYNJ2KDM4EABL1ALPL
SCHEMBL8838912 1.00 SLC6A2 (0.57) SLC6A2SYNJ2KDM4EABL1ALPL
SCHEMBL18718056 1.00 SLC6A2 (0.57) SLC6A2SYNJ2KDM4EABL1ALPL
SCHEMBL9155988 1.00 SLC6A2 (0.57) SLC6A2SYNJ2KDM4EABL1ALPL
SCHEMBL20056672 1.00 SLC6A2 (0.57) SLC6A2SYNJ2KDM4EABL1ALPL
SCHEMBL5026360 1.00 SLC6A2 (0.57) SLC6A2SYNJ2KDM4EABL1ALPL
SCHEMBL117781 1.00 SLC6A2 (0.57) SLC6A2SYNJ2KDM4EABL1ALPL
SCHEMBL9849387 1.00 SLC6A2 (0.57) SLC6A2SYNJ2KDM4EABL1ALPL
SCHEMBL5026366 1.00 SLC6A2 (0.57) SLC6A2SYNJ2KDM4EABL1ALPL
SCHEMBL18733414 1.00 SLC6A2 (0.57) SLC6A2SYNJ2KDM4EABL1ALPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140073589-A1 Amphetamine Prodrugs SHIRE AG (CH) 2014-03-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140073589-A1 Amphetamine Prodrugs SLC6A2, SLC6A3, TAAR5 SLC6A2 1/4885SYNJ2 3226/4885KDM4E 547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback